OSL 7.69% 1.4¢ oncosil medical ltd

Biography of Daniel Kenny - Management is key to a successful business... IMHO

  1. 748 Posts.
    lightbulb Created with Sketch. 4
    Management is key to a successful business... IMHO
    Biography of Daniel Kenny
    From Bloomberg Business

    * Mr. Daniel Kenny has been the Chief Executive Officer of Oncosil Medical Limited since January 5, 2015 and serves as its Managing Director.

    * Mr. Kenny served as Chief Commercial Officer and Vice President of Business Development at ABIVAX S.A. since October 2014.

    * He is an accomplished biopharmaceutical business leader, with almost 30 years' experience in the Global Pharmaceutical industry.

    * In his career he has developed and successfully driven business with industry leaders such as Roche (strategic marketing plans for the launch of Tamiflu(R) ) and Allergan. Prior to joining ABIVAX,

    * he served as Global Franchise Head at Baxter Vaccines. In this role, he led a successful reinvigoration of the base commercial business, significantly exceeding the financial plan for the Franchise in each of the three years of his tenure.

    * Before assuming this post, he served as Vice President Baxter BioScience, EMEA with responsibility for all marketing and key business programmes in support of regional sales exceeding $1.9billion.

    * He completed over 10 years in clinical research in the fields of ophthalmology and HIV/AIDS prior to join the pharmaceutical industry.

    * He has been a Director of Oncosil Medical Limited since November 28, 2014.

    * Mr. Kenny is a graduate in Physics from the University of New South Wales and has completed Executive business studies at both INSEAD and the London Business School.

    http://www.bloomberg.com/research/stocks/private/person.asp?personId=275657660&privcapId=23077988
 
watchlist Created with Sketch. Add OSL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.